GLP1R and cardiovascular disorder: As a regulator of glucose homeostasis, an exogenous GLP-1 analogue or potentiating endogenous GLP-1 by DPP-4 inhibitors show promise for the treatment of type 2 diabetes mellitus (T2DM) associated with cardiovascular disease.